Evidence map›Paper›PMID 33628596›Full record

ArticleCancer biology & medicine2021

A truncated protein product of the germline variant of the

Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu, Ying Yuan

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cancer biology & medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. A Novel Missense Variant ofHuman mutation · 2025
    Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mengyuan YangDepartment of Medical Oncology, Zhejiang University School of Medicine, Hangzhou 310009, China.
Yingxin ZhaoDepartment of Medical Oncology, Zhejiang University School of Medicine, Hangzhou 310009, China.
Yuwei DingDepartment of Medical Oncology, Zhejiang University School of Medicine, Hangzhou 310009, China.
Juan WangDepartment of Medical Oncology, Zhejiang University School of Medicine, Hangzhou 310009, China.
Yinuo TanDepartment of Medical Oncology, Zhejiang University School of Medicine, Hangzhou 310009, China.
Dong XuDepartment of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Ying YuanDepartment of Medical Oncology, Zhejiang University School of Medicine, Hangzhou 310009, China.ORCID /0000-0002-3922-9553
Zhejiang University · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: In some patients with adenomatous polyposis, an identifiable pathogenic variant of known associated genes cannot be found. Researchers have studied this for decades; however, few new genes have been identified. Methods: Adenomatous polyposis coli ( Results: From 88 patients with suspected familial adenomatous polyposis, 25 unrelated Conclusions: To our knowledge, this is the first study that reports the possible association of

Indexed as

Germ-Line MutationAdenomatous Polyposis ColiAdultCase-Control StudiesDual OxidasesFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedPedigreeYoung AdultDual OxidasesDUOX2 protein, humanAdenomatous polyposisDUOX2endoplasmic reticulum retentionunfolded protein responsewhole-exome sequencing

Identifiers

PMID33628596
PMCPMC7877186
OpenAlexW3096807391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.